6198 related articles for article (PubMed ID: 4005875)
1. Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation.
Chlebowski RT; Dietrich M; Akman S; Block JB
Cancer Treat Rep; 1985 May; 69(5):527-32. PubMed ID: 4005875
[TBL] [Abstract][Full Text] [Related]
2. Modulation of cytotoxicity of menadione sodium bisulfite versus leukemia L1210 by the acid-soluble thiol pool.
Akman SA; Dietrich M; Chlebowski R; Limberg P; Block JB
Cancer Res; 1985 Nov; 45(11 Pt 1):5257-62. PubMed ID: 2996758
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo.
Hitomi M; Yokoyama F; Kita Y; Nonomura T; Masaki T; Yoshiji H; Inoue H; Kinekawa F; Kurokohchi K; Uchida N; Watanabe S; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):713-20. PubMed ID: 15703828
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic activity of vitamins K1, K2 and K3 against human oral tumor cell lines.
Okayasu H; Ishihara M; Satoh K; Sakagami H
Anticancer Res; 2001; 21(4A):2387-92. PubMed ID: 11724297
[TBL] [Abstract][Full Text] [Related]
5. Synergistic cytotoxicity between menadione and dicumarol vs. murine leukemia L1210.
Akman SA; Doroshow JH; Dietrich MF; Chlebowski RT; Block JS
J Pharmacol Exp Ther; 1987 Feb; 240(2):486-91. PubMed ID: 2433429
[TBL] [Abstract][Full Text] [Related]
6. Abnormal deoxyuridine suppression as a rapid predictor for antimetabolite chemosensitivity: correlation with in vitro tests of growth inhibition.
Block JB; Chlebowski RT; Dietrich MF; Isacoff WH
Cancer Treat Rep; 1984 Apr; 68(4):631-6. PubMed ID: 6538809
[TBL] [Abstract][Full Text] [Related]
7. Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasms.
Su YZ; Duarte TE; Dill PL; Weisenthal LM
Cancer Treat Rep; 1987 Jun; 71(6):619-25. PubMed ID: 3581100
[TBL] [Abstract][Full Text] [Related]
8. Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells.
Ogawa M; Nakai S; Deguchi A; Nonomura T; Masaki T; Uchida N; Yoshiji H; Kuriyama S
Int J Oncol; 2007 Aug; 31(2):323-31. PubMed ID: 17611688
[TBL] [Abstract][Full Text] [Related]
9. Effects of the L isomer (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane on cell survival and cell cycle progression of cultured mammalian cells.
Traganos F; Darzynkiewicz Z; Melamed MR
Cancer Res; 1981 Nov; 41(11 Pt 1):4566-76. PubMed ID: 6171341
[TBL] [Abstract][Full Text] [Related]
10. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K
Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062
[TBL] [Abstract][Full Text] [Related]
12. Comparison of vitamins K1, K2 and K3 effects on growth of rat glioma and human glioblastoma multiforme cells in vitro.
Oztopçu P; Kabadere S; Mercangoz A; Uyar R
Acta Neurol Belg; 2004 Sep; 104(3):106-10. PubMed ID: 15508263
[TBL] [Abstract][Full Text] [Related]
13. [Human tumor stem cell assay].
Inoue K; Arakawa M; Ogawa M
Gan To Kagaku Ryoho; 1982 Apr; 9(4):599-605. PubMed ID: 7184417
[TBL] [Abstract][Full Text] [Related]
14. In vitro cytotoxicity of hepsulfam against human tumor cell lines and primary human tumor colony forming units.
Marshall MV; Marshall MH; Degen DR; Roodman GD; Kuhn JG; Ross ME; Von Hoff DD
Stem Cells; 1993 Jan; 11(1):62-9. PubMed ID: 8457783
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of in vitro assays for the cytotoxic effect of anticancer drugs].
Li XT; Lin C; Li PY
Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):184-6. PubMed ID: 3743346
[TBL] [Abstract][Full Text] [Related]
17. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
[TBL] [Abstract][Full Text] [Related]
18. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
19. Probenecid inhibition of methotrexate cytotoxicity in mouse L1210 leukemia cells.
Gangji D; Ross WE; Bleyer WA; Poplack DG; Glaubiger DL
Cancer Treat Rep; 1984 Mar; 68(3):521-5. PubMed ID: 6704981
[TBL] [Abstract][Full Text] [Related]
20. Modulation of thiol pools by vitamin K3 and its effect on survival of sensitive and resistant murine tumor cells.
Parekh H; Chavan S; Chitnis M
Anticancer Drugs; 1991 Apr; 2(2):159-68. PubMed ID: 1683589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
